UPDATE 2-Novavax aims at make 1 bln COVID-19 vaccine doses after buying plant

Novavax Inc is buying a manufacturing plant from privately held Serum Institute of India, the world's largest maker of vaccines by volume, as the U.S. company aims to produce 1 billion doses of its COVID-19 vaccine candidate next year.